![783-DA-R-EPOCH (dose adjusted rituximab etoposide prednisolone vinCRISTine CYCLOPHOSPHamide DOXO | eviQ 783-DA-R-EPOCH (dose adjusted rituximab etoposide prednisolone vinCRISTine CYCLOPHOSPHamide DOXO | eviQ](https://www.eviq.org.au/getmedia/697d4ac9-e60a-4f9c-8492-1097b4f25eb0/Alliance-CALGB-50303-Bartlett-Fig-2.png.aspx)
783-DA-R-EPOCH (dose adjusted rituximab etoposide prednisolone vinCRISTine CYCLOPHOSPHamide DOXO | eviQ
![Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing | Scientific Reports Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-017-17934-6/MediaObjects/41598_2017_17934_Fig4_HTML.jpg)
Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing | Scientific Reports
![Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis - Wallace - 2020 - ACR Open Rheumatology - Wiley Online Library Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis - Wallace - 2020 - ACR Open Rheumatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/48257d8f-b552-4af8-bf3d-718a8b5d8682/acr211133-fig-0001-m.jpg)
Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis - Wallace - 2020 - ACR Open Rheumatology - Wiley Online Library
![Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01789-0/MediaObjects/41591_2022_1789_Fig1_HTML.png)